资讯

contemporarypediatrics19 小时
Gena Schubert, D.O.
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics19 小时
Nathan Hitzeman, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics2 天
Validating a digital stethoscope for pediatric breath sounds, with Jennifer Nestor, MD
Jennifer Nestor, MD, evaluated a digital stethoscope to validate pediatric breath sound recordings for potential machine learning algorithm development. A recent study led by Jennifer Nestor, MD, ...
contemporarypediatrics1 天
Lori D. Frasier, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics2 天
Parents more likely to ask about guns in homes when they receive firearm safety information
Parents are more likely to ask about the presence of firearms in the homes their children visit when they receive gun safety information from a variety of sources, according to a new national study ...
contemporarypediatrics1 天
Charles J. Hyman, MD, FAAP
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics1 天
Melissa Blaker, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics1 天
Joshua Feder, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics2 天
Robert S Bahadori, MD, FACS, FAAOHNS
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics2 天
Mary Beth Miotto, MD, FAAP
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics2 天
Howard Fischer, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...
contemporarypediatrics2 天
Aline T Tanios, MD
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up ...